Q - Crexendo,

Adoption of New 10b5-1 Plan

On March 8, 2024, Jon Brinton, our Chief Revenue Officer, adopted a Rule 10b5-1 trading arrangement providing for the sale from time to time of up to 148,062 shares common stock. The number of shares that may be sold under the trading arrangement will be reduced by the number of shares (not yet determinable) withheld to satisfy tax obligations upon the vesting of certain outstanding equity awards. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c). The duration of the trading arrangement is effective until March 8, 2028, or earlier if all transactions under the trading arrangement are completed.

On December 9, 2024, Jeffrey Korn, our Chief Executive Officer, adopted a Rule 10b5-1 trading arrangement providing for the sale from time to time of up to 100,000 shares common stock. The number of shares that may be sold under the trading arrangement will be reduced by the number of shares (not yet determinable) withheld to satisfy tax obligations upon the vesting of certain outstanding equity awards. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c). The duration of the trading arrangement is effective until May 8, 2026, or earlier if all transactions under the trading arrangement are completed.

On December 9, 2024, Ronald Vincent, our Chief Financial Officer, adopted a Rule 10b5-1 trading arrangement providing for the sale from time to time of up to 150,000 shares common stock. The number of shares that may be sold under the trading arrangement will be reduced by the number of shares (not yet determinable) withheld to satisfy tax obligations upon the vesting of certain outstanding equity awards. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c). The duration of the trading arrangement is effective until May 8, 2026, or earlier if all transactions under the trading arrangement are completed.

On December 11, 2024, Douglas Gaylor, our President and Chief Operating Officer, adopted a Rule 10b5-1 trading arrangement providing for the sale from time to time of up to 120,000 shares common stock. The number of shares that may be sold under the trading arrangement will be reduced by the number of shares (not yet determinable) withheld to satisfy tax obligations upon the vesting of certain outstanding equity awards. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c). The duration of the trading arrangement is effective until May 8, 2026, or earlier if all transactions under the trading arrangement are completed.

Termination of 10b5-1 Plan

On May 29, 2025, David Wang, our Chief Technology Officer, terminated a Rule 10b5-1 trading arrangement providing for the sale from time to time of up to 400,000 shares common stock. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c). The duration of the trading arrangement was effective until December 31, 2025, or earlier if all transactions under the trading arrangement are completed.

On May 29, 2025, Anand Buch, our Chief Strategy Officer, terminated a Rule 10b5-1 trading arrangement providing for the sale from time to time of up to 600,000 shares common stock. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c). The duration of the trading arrangement was effective until December 31, 2025, or earlier if all transactions under the trading arrangement are completed.

No other directors or officers, as defined in Rule 16a-1(f), have adopted and/or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” each as defined in Regulation S-K Item 408, during the last fiscal quarter.